116 related articles for article (PubMed ID: 9357506)
1. Treatment of essential telangiectasias with an intense pulsed light source (PhotoDerm VL).
Raulin C; Weiss RA; Schönermark MP
Dermatol Surg; 1997 Oct; 23(10):941-5; discussion 945-6. PubMed ID: 9357506
[TBL] [Abstract][Full Text] [Related]
2. Treatment of linear and spider telangiectasia with an intense pulsed light source.
Retamar RA; Chames C; Pellerano G
J Cosmet Dermatol; 2004 Dec; 3(4):187-90. PubMed ID: 17166105
[TBL] [Abstract][Full Text] [Related]
3. Treatment of facial vascular lesions with intense pulsed light.
Angermeier MC
J Cutan Laser Ther; 1999 Apr; 1(2):95-100. PubMed ID: 11357295
[TBL] [Abstract][Full Text] [Related]
4. [Treatment of vascular malformations and pigment disorders of the face and neck by pulsed dye laser, Photoderm VL and Q-switched ruby laser].
Hellwig S; Schönermark M; Raulin C
Laryngorhinootologie; 1995 Oct; 74(10):635-41. PubMed ID: 8672204
[TBL] [Abstract][Full Text] [Related]
5. An intense light source. The photoderm VL-flashlamp as a new treatment possibility for vascular skin lesions.
Schroeter CA; Neumann HA
Dermatol Surg; 1998 Jul; 24(7):743-8. PubMed ID: 9693668
[TBL] [Abstract][Full Text] [Related]
6. [Treatment possibilities with a high-energy pulsed light source (PhotoDerm VL)].
Raulin C; Schroeter C; Maushagen-Schnaas E
Hautarzt; 1997 Dec; 48(12):886-93. PubMed ID: 9486359
[TBL] [Abstract][Full Text] [Related]
7. Treatment of a nonresponding port-wine stain with a new pulsed light source (PhotoDerm VL).
Raulin C; Hellwig S; Schönermark MP
Lasers Surg Med; 1997; 21(2):203-8. PubMed ID: 9261799
[TBL] [Abstract][Full Text] [Related]
8. Treatment of mature port wine stains with the PhotoDerm VL.
Cliff S; Misch K
J Cutan Laser Ther; 1999 Apr; 1(2):101-4. PubMed ID: 11357285
[TBL] [Abstract][Full Text] [Related]
9. Treatment of benign vascular lesions with the Photoderm VL high-intensity pulsed light source.
Goldman MP
Adv Dermatol; 1997; 13():503-21. PubMed ID: 9551153
[No Abstract] [Full Text] [Related]
10. Treatment of poikiloderma of Civatte using intense pulsed light source: 7 years of experience.
Rusciani A; Motta A; Fino P; Menichini G
Dermatol Surg; 2008 Mar; 34(3):314-9; discussion 319. PubMed ID: 18177401
[TBL] [Abstract][Full Text] [Related]
11. Intense pulsed light treatment of 1,000 consecutive patients with facial vascular marks.
Clementoni MT; Gilardino P; Muti GF; Signorini M; Pistorale A; Morselli PG; Cavina C
Aesthetic Plast Surg; 2006; 30(2):226-32. PubMed ID: 16547627
[TBL] [Abstract][Full Text] [Related]
12. Treatment of facial telangiectasias with a diode-pumped Nd:YAG laser at 532 nm.
Cassuto DA; Ancona DM; Emanuelli G
J Cutan Laser Ther; 2000 Sep; 2(3):141-6. PubMed ID: 11360331
[TBL] [Abstract][Full Text] [Related]
13. Photothermal sclerosis of leg veins. ESC Medical Systems, LTD Photoderm VL Cooperative Study Group.
Goldman MP; Eckhouse S
Dermatol Surg; 1996 Apr; 22(4):323-30. PubMed ID: 8624656
[TBL] [Abstract][Full Text] [Related]
14. Comparison of the 595 nm long-pulse (1.5 msec) and ultralong-pulse (4 msec) lasers in the treatment of leg veins.
Alora MB; Stern RS; Arndt KA; Dover JS
Dermatol Surg; 1999 Jun; 25(6):445-9. PubMed ID: 10469090
[TBL] [Abstract][Full Text] [Related]
15. Flashlamp-pumped pulsed dye laser therapy for poikiloderma of Civatte.
Wheeland RG; Applebaum J
J Dermatol Surg Oncol; 1990 Jan; 16(1):12-6. PubMed ID: 2299018
[TBL] [Abstract][Full Text] [Related]
16. Treatment of poikiloderma of Civatte using a redesigned pulsed dye laser with a 15 mm diameter treatment spot.
Bernstein EF; Schomacker K; Paranjape A; Jones CJ
Lasers Surg Med; 2019 Jan; 51(1):54-58. PubMed ID: 30480322
[TBL] [Abstract][Full Text] [Related]
17. Rhodamine intense pulsed light versus conventional intense pulsed light for facial telangiectasias.
Piccolo D; Crisman G; Kostaki D; Cannarozzo G; Sannino M; Chimenti S
J Cosmet Laser Ther; 2016; 18(2):80-5. PubMed ID: 26736070
[TBL] [Abstract][Full Text] [Related]
18. Treatment of poikiloderma of Civatte with the pulsed dye laser: a series of seven cases.
Langeland J
J Cutan Laser Ther; 1999 Apr; 1(2):127. PubMed ID: 12061380
[No Abstract] [Full Text] [Related]
19. Vascular-specific laser wavelength for the treatment of facial telangiectasias.
Dudelzak J; Hussain M; Goldberg DJ
J Drugs Dermatol; 2009 Mar; 8(3):227-9. PubMed ID: 19271368
[TBL] [Abstract][Full Text] [Related]
20. Successful Treatment of Lower Extremity Telangiectasias Using 585-nm Pulsed-Dye Laser at Low Fluence Combined With Optical Coherence Tomography: A Case Report.
Rajabi-Estarabadi A; Zheng C; Williams N; Smith SC; Nouri K; Kirsner RS
J Drugs Dermatol; 2019 Nov; 18(11):1180-1182. PubMed ID: 31741363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
